Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Autologous Cell Therapy Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Autologous Cell Therapy Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Autologous Cell Therapy Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- BioTime
- Pharmicell
- BrainStorm Cell Therapeutics
- Opexa Therapeutics
- Vericel Corporation
- Regeneus
- ...
By the Product Type, the market is primarily segmented into:
- Bone Marrow
- Epidermis
- Market segment by Application, split into
- Neurology
- Orthopedics
- Cancer
- Wound Healing
- Other
By Applications, the market is segmented into:
- Neurology
- Orthopedics
- Cancer
- Wound Healing
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Autologous Cell Therapy Market Report:
- To assess the size of the market by value and volume
- Analyze the Autologous Cell Therapy Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Autologous Cell Therapy Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Autologous Cell Therapy Market
The Autologous Cell Therapy Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Autologous Cell Therapy Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autologous Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bone Marrow
1.4.3 Epidermis
1.5 Market by Application
1.5.1 Global Autologous Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Neurology
1.5.3 Orthopedics
1.5.4 Cancer
1.5.5 Wound Healing
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Autologous Cell Therapy Market Perspective (2015-2026)
2.2 Autologous Cell Therapy Growth Trends by Regions
2.2.1 Autologous Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autologous Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Autologous Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Autologous Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Autologous Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autologous Cell Therapy Players by Market Size
3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autologous Cell Therapy Market Concentration Ratio
3.2.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2019
3.3 Autologous Cell Therapy Key Players Head office and Area Served
3.4 Key Players Autologous Cell Therapy Product Solution and Service
3.5 Date of Enter into Autologous Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Autologous Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Autologous Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Autologous Cell Therapy Market Size by Application (2015-2020)
5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autologous Cell Therapy Market Size (2015-2020)
6.2 Autologous Cell Therapy Key Players in North America (2019-2020)
6.3 North America Autologous Cell Therapy Market Size by Type (2015-2020)
6.4 North America Autologous Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autologous Cell Therapy Market Size (2015-2020)
7.2 Autologous Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Autologous Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Autologous Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China Autologous Cell Therapy Market Size (2015-2020)
8.2 Autologous Cell Therapy Key Players in China (2019-2020)
8.3 China Autologous Cell Therapy Market Size by Type (2015-2020)
8.4 China Autologous Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autologous Cell Therapy Market Size (2015-2020)
9.2 Autologous Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Autologous Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Autologous Cell Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autologous Cell Therapy Market Size (2015-2020)
10.2 Autologous Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autologous Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Autologous Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India Autologous Cell Therapy Market Size (2015-2020)
11.2 Autologous Cell Therapy Key Players in India (2019-2020)
11.3 India Autologous Cell Therapy Market Size by Type (2015-2020)
11.4 India Autologous Cell Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autologous Cell Therapy Market Size (2015-2020)
12.2 Autologous Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Autologous Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Autologous Cell Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 BioTime
13.1.1 BioTime Company Details
13.1.2 BioTime Business Overview and Its Total Revenue
13.1.3 BioTime Autologous Cell Therapy Introduction
13.1.4 BioTime Revenue in Autologous Cell Therapy Business (2015-2020))
13.1.5 BioTime Recent Development
13.2 Pharmicell
13.2.1 Pharmicell Company Details
13.2.2 Pharmicell Business Overview and Its Total Revenue
13.2.3 Pharmicell Autologous Cell Therapy Introduction
13.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2015-2020)
13.2.5 Pharmicell Recent Development
13.3 BrainStorm Cell Therapeutics
13.3.1 BrainStorm Cell Therapeutics Company Details
13.3.2 BrainStorm Cell Therapeutics Business Overview and Its Total Revenue
13.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
13.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
13.3.5 BrainStorm Cell Therapeutics Recent Development
13.4 Opexa Therapeutics
13.4.1 Opexa Therapeutics Company Details
13.4.2 Opexa Therapeutics Business Overview and Its Total Revenue
13.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
13.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
13.4.5 Opexa Therapeutics Recent Development
13.5 Vericel Corporation
13.5.1 Vericel Corporation Company Details
13.5.2 Vericel Corporation Business Overview and Its Total Revenue
13.5.3 Vericel Corporation Autologous Cell Therapy Introduction
13.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2015-2020)
13.5.5 Vericel Corporation Recent Development
13.6 Regeneus
13.6.1 Regeneus Company Details
13.6.2 Regeneus Business Overview and Its Total Revenue
13.6.3 Regeneus Autologous Cell Therapy Introduction
13.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2015-2020)
13.6.5 Regeneus Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Autologous Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Autologous Cell Therapy Revenue
Table 3. Ranking of Global Top Autologous Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bone Marrow
Table 6. Key Players of Epidermis
Table 7. Global Autologous Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Autologous Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Autologous Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Autologous Cell Therapy Market Share by Regions (2015-2020)
Table 11. Global Autologous Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Autologous Cell Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Autologous Cell Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Autologous Cell Therapy Players
Table 18. Global Autologous Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Autologous Cell Therapy Market Share by Players (2015-2020)
Table 20. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2019)
Table 21. Global Autologous Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autologous Cell Therapy Product Solution and Service
Table 24. Date of Enter into Autologous Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Autologous Cell Therapy Market Size Share by Type (2015-2020)
Table 28. Global Autologous Cell Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Autologous Cell Therapy Market Size Share by Application (2015-2020)
Table 30. Global Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Autologous Cell Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 34. North America Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Autologous Cell Therapy Market Share by Type (2015-2020)
Table 36. North America Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Autologous Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 40. Europe Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Autologous Cell Therapy Market Share by Type (2015-2020)
Table 42. Europe Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Autologous Cell Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 46. China Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Autologous Cell Therapy Market Share by Type (2015-2020)
Table 48. China Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Autologous Cell Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 52. Japan Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Autologous Cell Therapy Market Share by Type (2015-2020)
Table 54. Japan Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Autologous Cell Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 58. Southeast Asia Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Autologous Cell Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Autologous Cell Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 64. India Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Autologous Cell Therapy Market Share by Type (2015-2020)
Table 66. India Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Autologous Cell Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 70. Central & South America Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Autologous Cell Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Autologous Cell Therapy Market Share by Application (2015-2020)
Table 74. BioTime Company Details
Table 75. BioTime Business Overview
Table 76. BioTime Product
Table 77. BioTime Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 78. BioTime Recent Development
Table 79. Pharmicell Company Details
Table 80. Pharmicell Business Overview
Table 81. Pharmicell Product
Table 82. Pharmicell Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 83. Pharmicell Recent Development
Table 84. BrainStorm Cell Therapeutics Company Details
Table 85. BrainStorm Cell Therapeutics Business Overview
Table 86. BrainStorm Cell Therapeutics Product
Table 87. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 88. BrainStorm Cell Therapeutics Recent Development
Table 89. Opexa Therapeutics Company Details
Table 90. Opexa Therapeutics Business Overview
Table 91. Opexa Therapeutics Product
Table 92. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 93. Opexa Therapeutics Recent Development
Table 94. Vericel Corporation Company Details
Table 95. Vericel Corporation Business Overview
Table 96. Vericel Corporation Product
Table 97. Vericel Corporation Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 98. Vericel Corporation Recent Development
Table 99. Regeneus Company Details
Table 100. Regeneus Business Overview
Table 101. Regeneus Product
Table 102. Regeneus Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 103. Regeneus Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Bone Marrow Features
Figure 3. Epidermis Features
Figure 4. Global Autologous Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Neurology Case Studies
Figure 6. Orthopedics Case Studies
Figure 7. Cancer Case Studies
Figure 8. Wound Healing Case Studies
Figure 9. Other Case Studies
Figure 10. Autologous Cell Therapy Report Years Considered
Figure 11. Global Autologous Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Autologous Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Autologous Cell Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Autologous Cell Therapy Market Share by Players in 2019
Figure 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2019
Figure 18. North America Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BioTime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 27. Pharmicell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 29. BrainStorm Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 31. Opexa Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 33. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 35. Regeneus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
